Aim: Diyabetes mellitus (DM) is a majör risk factor for atheroscleros. Circulating monocyte count plays an important role for new atherosclerotic plaque development. Also, there is a strong inverse relationship between high density lipoprotein cholesterol (HDL) and atherosclerosis. Monocyte count/HDL ratio (MHR) is a novel inflammatory marker for atherosclerosis. Carotid intima-media thickness (CIMT) can predict the presence or absence of coronary artery disease (CAD). I aimed to investigate relationship between CIMT, MHR and type 2 DM Methods: A total of 120 patients were divided into two groups (with type2 DM group = 60, control group: 60).
INTRODUCTION
Atherosclerosis and CAD are among the leading causes of mortality in the world.
Diabetes mellitus is a major risk factor for atherosclerosis (1) . Often, atherosclerosis is detected at its advanced stages, and interventions are generally palliative or focused on secondary prevention (2) . Atherosclerosis manifests with subclinical signs long before it is clinically overt. Early detection and treatment of atherosclerosis in patients with DM prevent development of much pathology.
The most important changes that occur at the early stages of atherosclerotic disease include endothelial dysfunction and increased intima-media thickness. In many studies, detection of increased carotid intima-media thickness (CIMT) via non-invasive methods may predict the presence or absence of CAD (2, 3) .
Recently many studies have been conducted to understand the relationship between inflammation and atherosclerosis. These studies show significant relationships between atherosclerosis and are easily detectable by peripheral blood count parameters including platelet/lymphocyte ratio, neutrophil-lymphocyte ratio, and red blood cell distribution width (4, 5, 6) . In addition, monocytes and macrophages are known to play an essential role in the progression of atherosclerosis. One study demonstrated that monocyte count had predictive value in atherosclerotic plaque development (7) . Increased levels of serum (HDL), however, shows anti-atherogenic effects. High density lipoprotein inhibits the cytokine-induced expression of inflammatory adhesion molecules in endothelial cells. Monocyte count/HDL ratio is a novel inflammatory marker for atheroscleros. A recent study showed that MHR was negatively correlated with cardiovascular mortality in patients with chronic kidney disease (8) .
In this study, I examined the relationship between CIMT, which is an established indicator of subclinical atherosclerosis in patients with type 2 DM, and a novel index monocyte/HDL ratio
METHODS

Study population
This prospective study was conducted with 60 patients previously diagnosed with type 2 DM that were admitted to the cardiology clinic, and 60 healthy volunteers. All cases provided anamnesis and underwent general physical examination. Exclusion criteria included acute or chronic infection, malignancy, hematological disease, cerebrovascular accident, coronary artery disease, renal failure, connective tissue disease, acute coronary syndrome, decompensated heart failure, blood transfusion within a few months, and the use of antilipidemic drugs such as statin and niacin. The local ethics committee approved the study, and all patients included in the study provided proper written informed consent.
Study design
In all patients echocardiography was performed. Ejection fraction was calculated via M-mode technique. Carotid artery imaging was performed with the patient in the supine position and neck angled 20 degrees to the counter side. The measurements were made at 3 distinct points:
right and left carotid artery, bifurcation, and the first 2 cm of internal carotid artery. CIMT measurements were made by evaluating the posterior (far) wall only. Carotid intima-media thickness measurements were performed with B-mode examination in the long axis of the distance defined between vessel lumen echogenicity and media/adventitia echogenicity. Mean CIMT was calculated as the mean of the 3 measurements from both carotid arteries. Age, gender, body mass index (BMI), fasting blood glucose, creatinine, lipid profile, and systolic and diastolic blood pressures of the cases were evaluated. Additionally, hemoglobin A1c (HbA1c) levels were measured. Blood samples were obtained following a 12 hour fast. The monocyte/HDL ratio was calculated by dividing the monocyte count, measured via a complete blood count device, to the serum HDL level.
Statistical Analysis
All statistical calculations were performed using SPSS for Windows (ver. 21.0; SPSS, Chicago, IL, USA). Categorical variables were expressed as count and ratio. Continuous variables were expressed as mean ± standard deviation. Normality of the data distribution was analyzed with Kolmogorov-Smirnov test. The significance of the difference between the groups regarding mean values was analyzed with Student t-test. Comparison of categorical variables between the groups was made with chi-square test. Continuous non-parametric variables were compared between the groups with Mann-Whitney U test. Correlation analysis was made using Pearson's or Spearman's test. Logistic regression analysis was used to investigate the independent determinants of Type 2 Diabetes. In the logistic regression analysis, most deterministic factors in discriminating the groups were confirmed. A p-value of less than 0.05 was accepted as statistically significant.
RESULTS
Sixty patients diagnosed with Type 2 DM (mean age 60.8±8.2 years, 75.0% male), and 60 healthy individuals as the control group (mean age 61.3±7.4 years, 76.6% male) were included in the study. There were no differences between the groups regarding mean age, ejection fraction, clinical systolic or diastolic pressures, creatinine level, white blood cell count, or hemoglobin level (p>0.05). The Diabetes group had markedly higher body mass index (BMI), CIMT, MHR, fasting blood glucose, HbA1c, and low density lipoprotein (LDL) levels compared to the control (p<0.001 for all). Additionally, total cholesterol (TC) and triglyceride (TG) levels were significantly higher in the Diabetes group (p=0.002 and p=0.008, respectively). On the contrary, HDL levels were higher in the control group (p=0.010) ( Table 1) .
CIMT, BMI, HbA1c, TC, TG, and LDL levels showed significant correlation with blood glucose level (r=0.474, p<0.001; r=0.492, p<0.001; r=0.910, p<0.001; r=0.251, p=0.002; r=0.228, p=0.008; and r=0.392, p<0.001 respectively). On the other hand, HDL showed a negative correlation with blood glucose level (r=-0.202, p=0.010). Multivariate logistic regression analysis showed that CIMT, BMI, HbA1c and LDL levels were independent determinants of type 2 DM (Odds ratios (ORs)=1.967, 95% CI, 1.574-2.459, p < 0.001; OR=1.564, 95% CI, 1.402-2.102, p < 0.001; OR=1.102, 95% CI, 1.034-1.366, p = 0.012; OR= 1.017, 95% CI, 1.002-1.023, p=0.014, respectively) ( Table 2) . 
DISCUSSION
Patients with Type 1 or Type 2 DM are well known to have increased risk of atherosclerosis (9) . The most important change occurring at the early stage of atherosclerotic disease is increased intima-media thickness in the whole arterial bed. As early atherosclerotic changes occur in the vascular bed, intima-media thickening has been proposed to indicate endothelial dysfunction or concurrent involvement of both layers. Thus, in addition to clinical evaluation, the two powerful markers of subclinical vessel disease, coronary artery calcium scan and CIMT can be used discriminate low-and high-risk groups of Diabetic patients (10).
Moreover, CIMT has been generally associated with cardiovascular risk factors and extent of symptomatic CAD (11) . Additionally, various studies have documented the relationship between insulin resistance, hyperlipidemia, DM duration hyperglycemia and CIMT (12) . In found significantly higher monocyte ratio in the Diabetic group. Plasma HDL cholesterol level is associated with reduced cardiovascular mortality and morbidity, and the main mechanism underlying this protective effect is reverse cholesterol transport. High density lipoprotein concentration is often inversely associated with the plasma levels of proinflammatory agents, such as cytokines and CRP, in atherosclerotic cardiovascular diseases.
This highlights the importance of the balance between anti-inflammatory and proinflammatory potentials in the pathogenesis of these diseases. Besides many antiatherosclerotic effects, HDL has been suggested to be an inhibiting molecule against monocyte activation (16) . A recent study by Kanbay et al. found that b MHR was an independent predictive factor for composite and fatal cardiovascular events in 340 patients with chronic kidney disease (8) . Many studies have shown that MHR has predictive value in acute coronary syndromes, that it indicates high thrombus load, and is closely associated with stent thrombosis in patients undergoing coronary stent implantation with primary percutaneous intervention (17, 18) . Kızıltunç et al. found an association with MHR and the extent of atherosclerosis as indicated by Gensini score among patients with stable angina pectoris (19) . Another study by Canpolat et al. reported that high baseline MHR was associated with recurrent atrial fibrillation development in patients that underwent cryoablation due to atrial fibrillation (20) . In this study, I also found a significantly higher MHR in patients with Type 2 DM.
In conclusion, I found significantly higher MHR and CIMT in the diabetic group and I think MHR, which is an easily calculated index, can be used in the daily clinical practice as an indicator of atherosclerosis in Type 2 DM patients.
